Keynote: Jacques Turgeon

"The Need for Advanced Clinical Decision Support Systems for the Management of Patients with Polypharmacy"

Saturday, February 17, 2018 - 9:00-10:00 am
 
UAN: 0107-9999-17-254-L01-P | 0.1 CEU/1.0 hrs
UAN: 0107-9999-17-254-L01-T | 0.1 CEU/1.0 hrs
 
According to the US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) statistics, inadequate drug use is the 4th to 6th leading cause of deaths annually and is responsible for hospitalizations and medical visits to the emergency room and doctor’s office. The development and use of clinical decision support systems is an effective way to personalize a therapeutic regimen, prevent and manage drug interactions that contribute significantly to this statistic. Studies have shown that 50% of patients using 5-9 drugs daily have major interactions and serious side effects. This keynote session will review how a clinical decision support system can be used to quantify the risk for a patient to have a side effect based on 5 specific factors. Gain insight on how a clinical decision support system can be used in community pharmacy, hospital settings, and physician offices at the time of prescribing to better personalize the therapeutic regimen and take advantage of current scientific and clinical data.
 
Learning Objectives
Upon successful completion of this knowledge-based CPE activity, participants should be able to:
 
  1. Review the main risk stratification strategies in patients’ populations.
  2. Demonstrate the value of a stratification strategy based on patients’ drug regimen.
  3. Describe the major risk factors considered in an improved approach to the management of drug therapy.
  4. Discuss a clinical decision support system for the rapid assessment of the risk of adverse drug-related effects in a patient.
  5. Describe the necessary steps in the appropriate interpretation of information provided by a clinical decision support tool.
  6. Generate appropriate interventions and manage patients’ condition using a clinical decision support system.
Jacques Turgeon

Jacques Turgeon, BPharm, PhD

Chief Scientific Officer, Tabula Rasa Healthcare, USA
Dean, Tabula Rasa Healthcare University, USA
Professeur Émerite, Université de Montréal, Montréal, Canada